Dima Shulkin: Emerging Biomarkers for Early Prediction of Sepsis-Induced Shock
Dima Shulkin, Co-Founder and CTO at RobotDreams GmbH, shared a post on LinkedIn about a recent article by Jia Li et al, published in Frontiers in Pharmacology, adding:
“Could a blood test warn doctors hours before a sepsis patient takes a dangerous turn?
A 2026 review in Frontiers in Pharmacology by Li and colleagues explores that hope.
Sepsis is the body’s runaway reaction to infection.
When it goes far enough, blood pressure crashes and organs fail.
In some intensive care units, more than 4 in 10 of these patients die.
The authors look at tiny ‘warning signals’ in the blood that rise before the usual symptoms.
In one cited study of 142 patients, a signal called IL-6 correctly flagged the high-risk patients about 80 percent of the time.
Most signals still need testing before doctors can fully trust them.”
Title: Early biomarkers for predicting sepsis-induced shock: insights from inflammatory pathways and immune response
Authors: Jia Li, Qiufang Zhao, Haiyun Gao, Hongjun Wang, Cong Guo, Xiaoling Feng
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session